[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Revelation Biosciences Inc (REVB)

Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Revelation Biosciences Inc 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 USA

www.revbiosciences.com Employees: 9 P: 650-800-3717

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Revelation Biosciences Inc. is a clinical-stage life sciences company. It focused on the development of immunologic-based therapies for the prevention and treatment of disease. The company's product pipeline includes REVTx-99, REVTx-200 and REVDx-501. Revelation Biosciences Inc., formerly known as Petra Acquisition Inc., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 3,869
Enterprise Value, $K -6,831
Shares Outstanding, K 3,908
Float, K 3,721
% Float 95.20%
Short Interest, K 35
Short Float 0.88%
Days to Cover 1.00
Short Volume Ratio 0.29
% of Insider Shareholders 4.80%
% of Institutional Shareholders 12.80%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -8,910 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,010 K
EBIT, $ -10,060 K
EBITDA, $ -10,030 K

Growth:

1-Year Return -89.88%
3-Year Return -99.98%
5-Year Return -100.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.71 on 05/07/26
Next Earnings Date 08/06/26
Earnings Per Share ttm -39.48
EPS Growth vs. Prev Qtr -64.24%
EPS Growth vs. Prev Year 89.30%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 01/28/26

REVB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -107.65%
Return-on-Assets % -87.98%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.30
Book Value/Share 3.49
Interest Coverage -0.78
60-Month Beta -0.09
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.